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Contrasting metabolic effects of medium- versus long-chain fatty acids in
skeletal muscle
Abstract
Dietary intake of long-chain fatty acids (LCFAs) plays a causative role in insulin resistance and risk of
diabetes. Whereas LCFAs promote lipid accumulation and insulin resistance, diets rich in medium-chain
fatty acids (MCFAs) have been associated with increased oxidative metabolism and reduced adiposity,
with few deleterious effects on insulin action. The molecular mechanisms underlying these differences
between dietary fat subtypes are poorly understood. To investigate this further, we treated C2C12
myotubes with various LCFAs (16:0, 18:1n9, and 18:2n6) and MCFAs (10:0 and 12:0), as well as fed mice
diets rich in LCFAs or MCFAs, and investigated fatty acid-induced changes in mitochondrial metabolism
and oxidative stress. MCFA-treated cells displayed less lipid accumulation, increased mitochondrial
oxidative capacity, and less oxidative stress than LCFA-treated cells. These changes were associated with
improved insulin action in MCFA-treated myotubes. MCFA-fed mice exhibited increased energy
expenditure, reduced adiposity, and better glucose tolerance compared with LCFA-fed mice. Dietary
MCFAs increased respiration in isolated mitochondria, with a simultaneous reduction in reactive oxygen
species generation, and subsequently low oxidative damage. Collectively our findings indicate that in
contrast to LCFAs, MCFAs increase the intrinsic respiratory capacity of mitochondria without increasing
oxidative stress. These effects potentially contribute to the beneficial metabolic actions of dietary MCFAs.
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Abstract
Dietary intake of long-chain fatty acids (LCFA) plays a causative role in insulin resistance
and risk of diabetes. Whereas LCFA promote lipid accumulation and insulin resistance, diets
rich in medium-chain fatty acids (MCFA) have been associated with increased oxidative
metabolism and reduced adiposity, with little deleterious effects on insulin action. The
molecular mechanisms underlying these differences between dietary fat subtypes are poorly
understood. To investigate this further, we treated C2C12 myotubes with various LCFA
(16:0, 18:1n9, 18:2n6) and MCFA (10:0, 12:0), as well as fed mice diets rich in LCFA or
MCFA, and investigated fatty acid-induced changes in mitochondrial metabolism and
oxidative stress. MCFA-treated cells displayed less lipid accumulation, increased
mitochondrial oxidative capacity and less oxidative stress than LCFA-treated cells. These
changes were associated with improved insulin action in MCFA-treated myotubes. MCFAfed mice exhibited increased energy expenditure, reduced adiposity and better glucose
tolerance compared to LCFA-mice. Dietary MCFA increased respiration in isolated
mitochondria, with a simultaneous reduction in reactive oxygen species generation, and
subsequently low oxidative damage. Collectively our findings indicate that in contrast to
LCFA, MCFA increase the intrinsic respiratory capacity of mitochondria, without increasing
oxidative stress. These effects potentially contribute to the beneficial metabolic actions of
dietary MCFA.

Key Words
Metabolic disease, medium-chain fatty acids, mitochondrial metabolism, oxidative stress,
insulin signalling
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Introduction
The most common metabolic disorders in our western society (including obesity and insulin
resistance) have arisen to a great extent from excess nutrient intake, especially in the form of
fat. Intake of diets rich in long-chain fatty acids (LCFA, C>16), the most common fatty acid
(FA) type in western diets, is associated with disturbances in glucose homeostasis and insulin
action (1, 2). Many mechanisms have been proposed to underpin the deleterious effects of
LCFA on metabolic health, including increased inflammation, overactivation of stress-related
pathways and inappropriate lipid accumulation in non-adipose tissues (1, 3).
Interestingly, not all dietary fats induce the same degree of metabolic dysfunction. Our group
and others have shown that intake of equal-caloric diets rich in medium-chain fatty acids
(MCFA, C8-C12) decreases adiposity (4-6) and increases energy expenditure (7, 8) and
avoids many of the detrimental effects associated with LCFA intake. The increased energy
expenditure suggests that FA are funnelled into oxidative versus storage pathways, and this
has previously been suggested to be due to enhanced cellular uptake and entry of MCFA into
mitochondria (especially in the liver) for oxidation. In a recent study we showed that high-fat
diets enriched with MCFA caused a marked induction in mitochondrial oxidative capacity in
muscle, over and above that induced by a LCFA high-fat diet, suggesting that enhanced
myocellular oxidation of MCFA might also be a key pathway for oxidative disposal of this
class of FA (8). In conjunction with the increase in markers of mitochondrial metabolism,
MCFA also prevented lipid accumulation and insulin resistance in muscle, with similar
glucose uptake and muscle triglyceride levels in MCFA-fed animals compared with lean
animals fed a low-fat diet (8).
In this study, we have used in vitro and in vivo systems to further characterise the disparate
metabolic effects of MCFA and LCFA in muscle. Firstly, we have investigated whether in
addition to affecting mitochondrial content in muscle, MCFA and LCFA have differential
effects on the intrinsic bioenergetic capacity of mitochondria. Additionally, as mitochondria
are a major site for reactive oxygen species (ROS) production and LCFA have been linked
with oxidative stress (9, 10), we have determined the effect of MCFA and LCFA on ROS
production and markers of oxidative damage.

	
  
3	
  
	
  

Methods
Cell Culture
C2C12 myoblasts were grown in 1:1 Dulbecco’s Modified Eagle’s Medium (DMEM) and
Ham’s F-12 Nutrient Mix (Life Technologies, Mulgrave, VIC, Australia), containing 10%
HyClone bovine calf serum (Thermo Fisher Scientific, Scoresby, VIC, Australia) and
antibiotics (100 units/ml penicillin and 100 µg/ml streptomycin). Differentiation was induced
by serum-starvation using 2% horse serum (Life Technologies, Mulgrave, VIC, Australia)
once 90-100% confluence was reached. Cells were differentiated for 5 days, and
differentiated myotubes were incubated for 18 hours with individual FA. For the lipid
treatments, 200 µM FA in ethanol were conjugated to 1% FA-free BSA at 55°C for 1.5 hours
in differentiation media, the media was filter-sterilized and applied to the cells. Control cells
were incubated with an equal concentration of BSA and ethanol. For insulin stimulations,
myotubes were serum-starved for 4 hours (in the presence of the respective FA), stimulated
with 10 nM insulin for 30 min and lysed immediately in RIPA buffer for immunoblotting
(see below).
Succinate dehydrogenase activity
Cell lysates were used to measured succinate dehydrogenase activity. 10 µl of lysate was
mixed with 250 µl of reaction cocktail, containing 50 mM KH2PO4, 20 mM succinate, 2.5
µM Antimycin A, 2.5 mM sodium cyanide and 0.45 mM phenazine methosulphate, in a 96well plate. 50 µl of dichloroindophenol (0.72 mM) was added to the wells, and change in
absorbance measured at 600nm and 30°C. Protein concentration was measured using the
Bradford method.
Fatty acid uptake
For the determination of fatty acid uptake in cells, C2C12 myotubes were grown in 12-well
plates and treated for 18 hours with 200µM FA as described above. On the day of the assay,
200µM lauric acid-conjugated media containing 1µCi/ml [1-14C]-lauric acid (MP
Biomedicals, Singapore) was applied to cells pre-treated with MCFA and 200µM palmitic
acid-conjugated media containing 1µCi/ml [1-14C]-palmitic acid (Perkin Elmer, Melbourne,
VIC, Australia) was applied to cells pre-treated with LCFA for exactly 2 hours. Control cells
received both treatments. After the 2 hour incubation period, the media was acidified with
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1M perchloric acid, and evolved 14CO2 was captured in 1M NaOH. Acid-soluble metabolites
(ASM) in the media labelled with 14C were also determined. Cells were scraped into 200µl 1x
PBS + 0.05% SDS, sonicated, a sub-sample (20µl) taken for protein determination, and the
remainder used for lipid extraction. Lipids were extracted using 2:1 chloroform:methanol
following phase separation with 0.6% NaCl,

14

C in the lipid phase and aqueous phase

(representing cell ASM) were determined. Total fatty acid uptake was calculated as the sum
of FA that were funnelled into oxidation (CO2 + ASM in media + ASM cell counts) and the
lipid fraction. Protein content was determined using the BCA assay (Pierce, Thermofisher
Scientific, Scoresby, VIC, Australia).
Superoxide production in cells
For the determination of mitochondrial as well as cytosolic superoxide production, C2C12
myoblasts were grown in black (clear-bottom) 96-well plates, differentiated and treated with
MCFA and LCFA for 18 hours as described above. On the day of the experiment, FAcontaining differentiation media was replaced with HBSS buffer (Life Technologies,
Mulgrave, VIC, Australia), also containing FA (conjugated to BSA) and either the
mitochondrial fluorophor MitoSOX Red (5 µM, in nitrogen-bubbled DMSO), the cytosolic
superoxide marker dihydroethidium (DHE; 20µM, in nitrogen-bubbled DMSO) or DMSO
itself. MitoSOX Red and DHE were added from stock solutions in DMSO with the final
concentration of DMSO being less than 0.2% (v/v). Cytosolic superoxide generation with
DHE was measured in the absence or presence of the NAD(P)H oxidase inhibitor VAS2870
(10µM). Time-resolved fluorescence was determined for 1 hour using a BMG Labtech
FLUOstar OPTIMA platereader and 485nm/590nm excitation/emission filters. Changes in
fluorescence in the MitoSOX Red- or DHE-treated cells were corrected for slope observed in
the DMSO-treated cells (for each individual FA treatment). Results are expressed as change
in fluorescence/min/mg protein. For the determination of protein content, media was removed
from the wells, 10 µl 1 M KOH added to lyse the cells, topped up with 190 µl of ddH2O, and
protein concentration measured using the Bradford method (Bio-Rad Laboratories, Regents
Park, NSW, Australia).
Glycogen synthesis
C2C12 myotubes were grown in 12-well plates and treated with 200µM FA as described
above. On the day of the assay, cells were serum-starved for 4 hours in the presence of the
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respective FA, followed by a 1-hour incubation in serum-free media containing FA and
4µCi/ml

14

C-glucose (Perkin Elmer, Melbourne, VIC, Australia), and in the absence (basal

state) or presence (insulin-stimulated state) of 100nM Insulin. Cells were washed 3 times in
PBS, scraped into 100µl 1M KOH and heated for 15min to 75°C. A sub-sample (10µl) was
taken for protein determination. To the remainder, 30µl 25mg/ml glycogen, 20µl saturated
Na2SO4 and 450µl ice-cold ethanol was added, the mix vortexed and frozen for 30min at 80°C, followed by a centrifugation step (10min, 13000 rpm, 4°C). Pellets were washed by
resuspension in 50µl ddH2O, followed by addition of 1ml ice-cold ethanol and
recentrifugation. The final pellet was resuspended in 50µl ddH2O and counted for
radioactivity.
Animal maintenance
Eight-week old male C57BL/6J mice were purchased from the Australian Resource Centre
(Perth, Australia). Mice were maintained in a temperature-controlled room (22±1°C) with a
12 h light/dark cycle and ad libitum access to food and water. After 1 week on a standard
low-fat chow diet (CHOW; 8% of calories from fat, 21% of calories from protein, 71% of
calories from carbohydrate; Gordon’s Specialty Stock Feeds, Yanderra, NSW, Australia),
mice were randomly allocated to remain on the CHOW diet or to receive a diet enriched in
either MCFA or LCFA ad libitum for 8 weeks. The high-fat diet (45% of calories from fat
[from hydrogenated coconut oil for the MCFA diet and from lard for the LCFA diet], 20% of
calories from protein, 35% of calories from carbohydrate) was made in-house and is based on
rodent diet no. D12451 (Research Diets, New Brunswick, NJ, USA). The dietary fatty acid
composition was described previously (8). Tissue samples were collected from mice at
09:00–10:00 hours without any prior fasting period. All experiments were approved by the
Garvan Institute/St Vincent’s Hospital Animal Experimentation Ethics Committee, and
followed guidelines issued by the National Health and Medical Research Council of
Australia.
Determination of body composition and energy expenditure
Lean and fat mass were measured in mice using dual-energy x-ray absorptiometry (DXA)
(Lunar PIXImus2 densitometer; GE Healthcare, Little Chalfont, UK). The rate of oxygen
consumption (VO2) and respiratory exchange ratio (RER) of individual mice were measured
using an Oxymax indirect calorimeter over 24-hours following an overnight acclimatisation
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period in the Oxymax cages and a 2-hour settling period (Columbus Instruments, Columbus,
OH, USA) as previously described (11).
Glucose tolerance and insulin levels
Mice were fasted overnight and injected i.p. with glucose (2 g/kg), and blood glucose levels
were monitored using an Accucheck II glucometer (Roche Diagnostics, Castle Hill, NSW,
Australia) for 90 min following glucose injection. Plasma insulin levels after overnight fast
were determined by radioimmunoassay (Linco Research, St Charles, MO, USA).
Isolation of mitochondria
Muscle mitochondria (from mixed hindlimb muscle) were isolated by differential
centrifugation as described previously (12). Briefly, muscle was diced in CP-1 medium (100
mM KCl, 50 mM Tris/HCl, pH 7.4, and 2 mM EGTA), digested on ice for 3 min in CP-2
medium [CP-1, to which was added 0.5% (w/v) BSA, 5 mM MgCl2, 1 mM ATP and 2.45
units ml–1 Protease Type VIII (Sigma P 5380)] and homogenized using an ultraturrax
homogenizer. The homogenate was spun for 5 min at 500 g and 4°C. The resulting
supernatant was subjected to a high-speed spin (10,600 g, 10 min, 4°C) and the pellet was
resuspended in CP-1. The high-speed spin cycle was repeated twice. Protein content was
measured using the Bradford method.
Respiration in cells and isolated mitochondria
For the determination of respiration in C2C12 myotubes, cells were incubated with FA for 18
hours as described above, trypsinized into 1ml FA-containing media and oxygen
consumption was measured at 37°C in a Clark-type oxygen electrode (Strathkelvin
Instruments, Motherwell, Scotland). In isolated mitochondria, oxygen consumption was
measured in air-saturated respiration buffer (120 mM KCl, 5 mM K2HPO4, 3 mM Hepes, 1
mM EGTA, 0.3% (w/v) defatted BSA, pH 7.2), which was calculated to contain 406 nmol
oxygen/ml (13), and to which was added either succinate (5mM) and rotenone (2µM) or
palmitoyl carnitine (40µM) + 2 mM malate as substrates. Oxygen consumption was measured
in state II (in the presence of substrate), state III (after addition of 200 µM ADP) and in state
IV (after addition of 2.5 µg/ml oligomycin). The respiratory control ratios (state III/state IV
respiration) were above 3.5 for succinate and above 5.0 for palmitoyl carnitine as substrates,
indicating well-coupled mitochondria.
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Mitochondrial H2O2 production
Hydrogen peroxide production in isolated mitochondria was determined by monitoring the
oxidation of Amplex Ultra Red (Invitrogen, Mount Waverley, VIC, Australia) using a
FLUOstar OPTIMA fluorescence plate reader, maintained at 37°C. Mitochondria were
incubated at 0.25 mg/ml in assay medium (120 mM KCl, 3 mM Hepes, 1 mM EGTA, 0.3%
BSA, pH 7.2 at 37°C) containing 6 u/ml horseradish peroxidase, 30 u/ml superoxide
dismutase and 0.1 mM Amplex Ultra Red, as described previously (14). H2O2 production was
determined under 3 conditions: in the presence of succinate (5mM), succinate and rotenone
(2µM, to inhibit electron backflow towards complex I) and in the presence of palmitoyl
carnitine (40µM). In separate wells containing assay medium, H2O2 was injected (using on
board injectors) at concentrations between 0 and 500nM and a standard curve calculated.
H2O2 production and state II oxygen consumption were used to calculate the percentage of
electrons which leak out of sequence producing superoxide and subsequently hydrogen
peroxide (15). Whereas two electrons are needed for the reduction of 1 mol of O2 to H2O2,
four electrons are transferred in the reduction of 1 mol of O2 to water. Therefore, the percent
free radical leak (FRL) was calculated as the rate of H2O2 production divided by twice the
rate of oxygen consumption, and the result was multiplied by 100 (16).
Lipid accumulation
Triacylglycerol (TAG) content was determined using a colorimetric assay kit (Triglycerides
GPO-PAP; Roche Diagnostics, Indianapolis, IN, USA) as previously described (17). For
diacylglycerol (DAG) and ceramide measurements, lipids were extracted from muscle in
solvents containing 2 nmol ceramide (17:0) and 10 nmol DAG (17:0/17:0) (18). DAG and
ceramide levels were measured using a hybrid linear ion trap–triple quadrupole mass
spectrometer (QTRAP 5500: AB Sciex, Foster City, CA, USA). Ceramide molecular lipids
were analysed by precursor-ion scanning for protonated dehydrated sphingosine at m/z 264.3.
DAG molecular lipids were analysed by multiple neutral-loss scanning for ammoniated fatty
acids. Data were analysed and quantified with LipidView (AB Sciex) version 1.1 after
isotope correction (19).
Immunoblotting
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Lysates were prepared from FA-treated C2C12 myotubes and mouse muscle mitochondria.
Cells were collected in RIPA buffer (20), sonicated for 5 sec, rotated at 4°C for 2 hrs and
centrifuged for 10 min at 16,000 g. Mitochondria were isolated as described above, mixed 1:1
in RIPA buffer and sonicated for 5sec. For both cells and mitochondria, 20 µg of protein was
denatured in Laemmli buffer at 65°C for 15 min, resolved by SDS-PAGE, electrotransferred
and immunoblotted, as described previously (21). Immunolabelled bands were quantified
using ImageJ 1.44p software.
Measurement of antioxidant protection and oxidative damage
Glutathione peroxidase (GPx) activity was measured as the decrease in NADPH absorption at
340 nm and 30°C. A reaction cocktail was prepared by mixing azide buffer (9.2 ml, 50 mM
NaH2PO4, 0.4 mM EDTA, pH = 7.0 at 30°C, addition of 1 mM Na-azide), glutathione
reductase (100 µl, 100 u/ml) and GSH (50 µl, 200 mM) into a 1 mg beta-NADPH vial
(Sigma N0411). Sample and reaction cocktail were mixed and H2O2 (5 µl, 0.042% (v/v)) was
added to start the reaction.
Lipid hydroperoxides (LOOH) were measured according to the method by Bou et al. 2008
(22). Thiobarbituric acid reactive substances (TBARS) and protein carbonyls were measured
in homogenates as described previously (14). Homogenate protein content was measured
using the Bradford method.
Statistical analysis
All results are presented as mean ± SEM. Results were compared using a one-way ANOVA
with P<0.05 considered significant, followed by a Fisher’s LSD test. For both the cell culture
and animal experiments, the mean of each treatment group was compared with the mean of
every other treatment group.
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Results
Effect of FA subtypes on oxidative metabolism and lipid accumulation in C2C12 myotubes
Incubation of myotubes with the MCFA capric (C10:0) and lauric acid (C12:0) for 18 hours
significantly increased oxygen consumption (Fig. 1A) and SDH activity (Fig. 1B) in
comparison to BSA-treated control cells, as well as protein levels of several oxidative
proteins, including sub-units of the mitochondrial electron transport chain, the masterregulator of mitochondrial biogenesis PGC1α, the mitochondrial content marker porin and
the mitochondrial fatty acid transporter CPT1 (Fig. 1C and Supplemental Table 1). The
observed increase in SDH activity was most likely due to increased protein expression, as
shown by immunoblotting for SDHa (Fig. 1C). In contrast, treatment of myotubes with
LCFA, the saturated FA palmitic acid (C16:0), the mono-unsaturated FA oleic acid
(C18:1n9) and the polyunsaturated FA linoleic acid (C18:2n6), did not significantly affect
cellular respiration (Fig. 1A), had no effect or caused a decrease in the expression of
oxidative proteins (Fig. 1C and Supplemental Table 1), and caused a mild decrease in
succinate dehydrogenase (SDH) activity compared to control cells (Fig. 1B). Protein levels of
the glucose transporter GLUT4 were unaffected by FA treatment (Fig. 1C).
Incubation of C2C12 myotubes with LCFA led to an average 5-fold increase in
triacylglycerol (TAG) accumulation in comparison to BSA-treated control cells.
Interestingly, myotubes incubated with the MCFA exhibited markedly less TAG
accumulation compared to the LCFA-treated cells (Fig. 1D). The differences in TAG
deposition were not due to any differences in FA uptake, as similar levels of uptake were
observed for both MCFA- and LCFA-treated cells with

14

C-labelled fatty acids (Fig. 1E).

Collectively these results suggest enhanced partitioning of FA towards oxidation with
MCFA, and the tracer experiments showed that approximately 65% of 14C-lauric acid taken
up was directed to oxidative pathways (CO2 and ASM), while this was only approximately
35% with 14C-palmitic acid (data not shown).
Effect of FA subtypes on oxidative stress in C2C12 myotubes
In addition to effects on lipid accumulation and mitochondrial metabolism, LCFA have also
been linked to oxidative stress and the subsequent accumulation of oxidatively damaged
cellular components (9, 10). We investigated the effect of incubation of C2C12 myotubes
with LCFA and MCFA on superoxide generation and lipid peroxidation (2 markers
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examined: lipid hydroperoxides (LOOH) and TBARS). Mitochondrial (Fig. 2A), but not
cytosolic superoxide generation (Fig. 2B), was significantly increased with all three LCFA,
but not after MCFA treatment. Cytosolic superoxide was measured in the absence and
presence of the NAD(P)H oxidase inhibitor VAS2870. Addition of VAS2870 decreased ROS
generation to approximately 90-95% of the rates measured in the absence of the inhibitor,
showing that NAD(P)H oxidases have only a minor contribution to cytosolic ROS production
in C2C12 myotubes (data not shown). Both lipid peroxidation markers followed the same
pattern as mitochondrial superoxide and were significantly increased after LCFA but not
MCFA treatment (Fig. 2 C+D). This highlights that MCFA keep oxidative stress at low
levels, whereas LCFA lead to substantial increase in mitochondrial ROS production and to
the accumulation of oxidative damage.
Effect of FA subtypes on insulin action in C2C12 myotubes
Excess lipid accumulation, mitochondrial dysfunction and oxidative stress have been
associated with the development of insulin resistance (1). We next investigated how
incubation of myotubes with LCFA and MCFA affected insulin-stimulated phosphorylation
of IRS1 (Tyr612), Akt (Ser473) and GSK3β (Ser9), as well as the insulin-stimulated
glycogen synthesis rate (Fig 3). Whereas none of the FA had an effect on phosphorylation of
IRS1, incubation of muscle cells with MCFA significantly increased Akt phosphorylation. In
contrast, palmitic acid decreased insulin-stimulated Akt phosphorylation substantially,
whereas no changes were observed with oleic or linoleic acid. Phosphorylation of GSK3β
was decreased after LCFA but not MCFA treatment, which was accompanied by a significant
decrease in insulin-stimulated glycogen synthesis rate with all three LCFA (Fig. 3). These
results suggest that MCFA, unlike LCFA, do not impair insulin action in muscle cells.
Effect of dietary MCFA and LCFA intake on adiposity, energy expenditure and glucose
tolerance
Mice fed a MCFA-rich diet were partially protected from body weight gain and increases in
adiposity in comparison to LCFA-fed mice (when compared to chow controls) after 8 weeks
of high-fat feeding (Fig. 4 A+B). The differences in body composition in MCFA- and LCFAfed mice can be to some extent explained by differences in energy intake, as cumulative
calorie intake per mouse over the 8-week feeding period was increased in the MCFA- and
LCFA-groups when compared to the CHOW-fed mice (CHOW 11.1 ± 0.6; MCFA 12.8 ±
	
  
11	
  
	
  

0.6; LCFA 12.3 ± 0.6 kcal/day). We did not assess if there were differences in lipid
absorption between the two diets, however, MCFA are more efficiently absorbed then LCFA
(23), and thus differences in energy dissipation by inefficient digestion of the dietary fatty
acids is unlikely to underlie the differences in adiposity and body composition. Whole-body
oxygen consumption (normalised to lean mass) was elevated in both fat-fed groups compared
to controls, and was significantly higher in MCFA- vs. LCFA-fed animals in both the light
and dark phase (Fig. 4 C). Furthermore, the respiratory exchange ratio (RER) showed a
greater decrease in MCFA-mice than in LCFA-mice compared to control chow-fed mice
(Fig. 4 D). The increase in overall energy expenditure and the lower RER could partly
explain the reduced adiposity in MCFA-fed mice. Compared to LCFA-mice, MCFA-fed
animals also did not develop the same degree of high-fat diet-induced glucose intolerance
(Fig. 4 E) and displayed lower fasting insulin levels (Fig. 4 F).
Effect of dietary MCFA and LCFA intake on muscle lipid accumulation
MCFA-fed mice displayed less muscle triacylglycerol (TAG) accumulation than LCFA-fed
mice (41% increase with MCFA vs. 295% increase with LCFA) (Fig. 5A). A similar
proportional increase was also observed in diacylglycerol (DAG) accumulation, whereas total
ceramide levels were greatest in muscle from MCFA-fed mice (Fig. 5B). The increase in
muscle ceramide in MCFA-fed mice was mainly due to an increase in CER18:0 and CER24:0
(Fig. 5C), while the increase in total DAG in MCFA- and LCFA-fed mice was due to an
elevation in the same DAG species, mainly DAG16:0/16:0, DAG 16:0/18:0 and
DAG16:1/18:1 (Supplemental Fig. 1).
Effect of dietary MCFA and LCFA intake on mitochondrial respiration and ROS
production
To determine if MCFA altered mitochondrial function, oxygen consumption in states II, III
and IV was measured in isolated muscle mitochondria using succinate and palmitoyl carnitine
as substrates. Mitochondria from muscle of MCFA-mice showed significantly greater rates of
oxygen consumption than chow- and LCFA-fed animals in state III for both succinate and
palmitoyl carnitine (Fig. 5 A+B). Increased mitochondrial substrate flux is often
accompanied by higher ROS production, however the mitochondria from MCFA-fed mice
displayed a 32% decrease in H2O2 generation in the presence of succinate (when compared to
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LCFA-mice), with no difference in ROS production detected when palmitoyl carnitine was
used as a substrate for the electron transport chain (ETC) (Fig. 5 C).
Using certain assumptions (see methods section), it is possible to calculate the percentage of
electrons that leak out of sequence during electron transfer in the ETC, and, rather than being
transferred to molecular oxygen as final electron acceptor, leak out and produce superoxide.
This has been called the free radical leak (FRL) (16). With succinate (in the presence of
rotenone), muscle mitochondria from MCFA-fed mice displayed a 40% decrease in FRL,
with no change observed in the LCFA-animals in comparison to controls. In contrast, with
palmitoyl carnitine the FRL was two-fold higher in LCFA-mice than in MCFA- or chow-fed
mice (Fig. 5D). Both substrates point towards a MCFA-rich diet having beneficial effects on
mitochondrial electron leakage, with less superoxide molecules produced per consumed
oxygen molecule.
Effect of dietary MCFA and LCFA intake on protein expression of mitochondrial oxidative
proteins
Immunoblotting of mitochondrial lysates was undertaken to investigate if the increased
oxygen consumption in isolated mitochondria from MCFA-fed mice might be due to
alterations in the expression of key oxidative proteins. Equal amounts of mitochondria from
each dietary group were used for immunoblotting, as shown by quantification of the abundant
mitochondrial transmembrane protein porin (Fig. 6). Protein expression of sub-units of
complexes I-V of the ETC, as well as uncoupling protein 3 (UCP3), were increased to a
greater extent with the MCFA- than the LCFA-diet, when compared to mitochondria from
chow-fed controls (Fig. 6). Superoxide dismutase 2 (SOD) was significantly decreased in the
MCFA-mice, whereas no difference was observed in carnitine palmitoyl transferase 1 (CPT1)
protein content between diet groups. These data suggest that MCFA more effectively
promote the expression of oxidative proteins than LCFA, resulting in increased oxidative
capacity per unit of mitochondria.
Effect of dietary MCFA and LCFA intake on oxidative stress in muscle
As described above, in both muscle cells and mitochondria from mouse muscle, MCFA were
associated with lower rates of ROS production. To determine if this was accompanied by
differences in the accumulation of oxidative damage in mouse skeletal muscle (as done in
C2C12 myotubes), we measured various antioxidant and oxidative damage markers.
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Antioxidant systems are expected to respond to the need of a tissue for protection, with
greater oxidative stress levels resulting in an increase in the expression and activity of
antioxidant enzymes (24). Glutathione peroxidase, as well as the content of lipid
hydroperoxides (an intermediate marker of oxidative damage to lipids) and protein carbonyls
(marker for oxidative damage to proteins), were increased with the LCFA-, but not the
MCFA-diet (Fig. 7 A-C). TBARS, an endpoint marker of lipid peroxidation, remained
unchanged in muscle of LCFA-fed mice, but was significantly decreased in MCFA-mice,
when compared to controls (Fig. 7 D). Overall, these data indicate that MCFA in contrast to
LCFA do not increase mitochondrial ROS production in vivo, with subsequently less
accumulation of oxidatively damaged lipids and proteins.
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Discussion
Over the last 20 years, it has been repeatedly described that diets rich in LCFA (e.g. typical
western diets) lead to the development of adiposity and insulin resistance, and increase the
risk of diabetes (1, 25). In contrast, diets rich in MCFA, when used at an equal-caloric level,
do not induce the same degree of detrimental effects on metabolic health; despite a similar
increase in dietary fat intake as with the LCFA diet (4-8). These favourable effects have been
partially ascribed to the physical properties of MCFA, because this class of FA is more
readily funnelled into oxidative pathways, which could lead to increased energy expenditure
and less fat deposition in adipose and other tissues compared to LCFA (26). The tissue that is
likely to be responsible for many of the beneficial effects of MCFA on whole-body glucose
homeostasis is skeletal muscle, where previous studies from our group have shown that a
MCFA-rich diet leads to a substantially greater increase in markers of mitochondrial content
than LCFA, and a prevention of lipid accumulation and insulin resistance in this tissue (8). In
the current study, we have shown that the beneficial effects of MCFA in skeletal muscle may
also be related to changes at the level of mitochondria, where we observed increased
respiratory capacity and reduced ROS production.
Whereas a variety of studies demonstrated a link between muscle mitochondrial oxidative
capacity and insulin action (8, 27, 28), other publications showed no such correlation
(summarized in 29). Here we show that MCFA induced an increase in respiration and SDH
activity in muscle cells, as well as an increased protein expression of various mitochondrial
proteins, suggesting an improvement in mitochondrial oxidative capacity, while no such
increases were observed after LCFA treatment. Importantly, experiments in isolated
mitochondria from skeletal muscle of MCFA-fed mice showed that per unit of mitochondria
there was increased respiratory capacity, which is likely explained by an increase in the
expression of oxidative proteins. Previous studies have shown that changes in the expression
and activity of oxidative proteins and the capacity for substrate oxidation can occur in muscle
without marked changes in total mitochondrial number, indicating improved intrinsic
capacity per mitochondrion (28, 30). The findings of the current study and our previous
report (8) indicate that MCFA improve mitochondrial substrate oxidation in muscle to a
greater extent than LCFA, due to increases in both the total number of mitochondria and the
oxidative capacity of individual mitochondria.
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Collectively the changes in mitochondrial content and capacity could, in part, explain the
enhanced whole-body energy expenditure per unit lean mass, the prevention of TAG and
DAG accumulation in muscle and the better insulin action in MCFA- vs. LCFA-fed animals
(current study and 8). We did observe a slight increase in total ceramide content in muscle
from the MCFA-fed mice, and despite ceramide accumulation being previously associated
with the development of insulin resistance, recent studies suggest that the FA chain length of
the ceramide species is important in determining its metabolic impact (31, 32). The increase
in muscle ceramide in MCFA-fed mice was mainly due to an increase in CER18:0 and
CER24:0 (Fig. 5C), with CER24:0 having previously been reported to have beneficial antiapoptotic effects (31). Importantly, we have shown that the effects of MCFA to boost
mitochondrial metabolism and avoid excess lipid deposition and insulin resistance are not
uniform across tissues. In our previous work we demonstrated that dietary MCFA, while
improving metabolic parameters in muscle, led to steatosis in the liver, likely due to
upregulation of lipogenic pathways, and hepatic insulin resistance (8). In the current cohort of
animals, we similarly observed that hepatic lipid accumulation was increased after LCFAfeeding, and to an even greater extent after MCFA-feeding (data not shown). While excess
hepatic lipid can have deleterious metabolic effects, it should be noted that many studies in
rodents and humans have reported no adverse effects of MCFAs on liver lipid levels (4, 26,
33, 34). These disparate findings on liver lipid accumulation between studies indicates that
differences in methodological factors may also be important, such as the exact composition
and fat content of the MCFA enriched diets, as well as the composition of the other
macronutrients in the diet.
Another intriguing finding of the current investigation was the disparate effects of MCFA and
LCFA on mitochondrial ROS production in muscle. Mitochondria are known to leak
electrons during electron transfer along the respiratory chain. This electron leak leads to the
generation of superoxide anions (an oxygen molecule with an unpaired electron), and
subsequently to the production of hydrogen peroxide (H2O2), both reactive oxygen species
being highly damaging to any molecule they encounter (35). ROS generation is dependent
upon the redox state of the mitochondria, substrate concentration and substrate type.
Compared with carbohydrates, reducing equivalents from lipid oxidation produce increased
superoxide (36, 37). While still controversial, the majority of recent studies have proposed
that mitochondrial ROS generation is an important early event in the induction of insulin
resistance, with LCFA increasing ROS production and promoting insulin resistance (9, 10,
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38-40). Other publications support the view that cytosolic ROS, at low levels, are important
for normal insulin signalling and do not induce insulin resistance (41, 42). In conjunction
with both views, diets rich in LCFA have also been reported to decrease antioxidant
protection, thereby promoting oxidative damage (40, 43), whereas other reports demonstrated
that antioxidants do not improve insulin action, especially in insulin-resistant humans
(summarized in 44). Little is known about the effects of MCFA on ROS generation and the
accumulation of oxidative damage. Here we have shown that in response to MCFA, both
mitochondrial superoxide generation in C2C12 myotubes, as well as mitochondrial H2O2
production in mouse skeletal muscle, was similar or decreased compared to controls. This
pattern can be explained by low levels of free radical leakage from the ETC in muscle
mitochondria from MCFA-fed mice, as measured by percentage of electrons leaking out of
sequence during mitochondrial respiration. In contrast, mitochondrial superoxide production
was substantially increased in LCFA-treated cells and in skeletal muscle of mice fed a LCFArich diet there was a 2-fold increase in FRL with the lipid-based substrate palmitoyl carnitine.
Cytosolic superoxide production, measured in the C2C12 myotubes, was significantly
reduced in response to both MCFA and LCFA treatments, indicating that mitochondrial ROS
generation is likely to be a more important mediator of changes in cellular oxidative status, as
recently suggested (45, 46).
In healthy systems, ROS are detoxified by various antioxidant systems. However, in diseased
states and during long-term dietary LCFA intake, this ‘oxidant–antioxidant’ balance has been
shown to be tilted in favour of the reactive species, resulting in ROS-mediated damage to
lipids, proteins and DNA (47). To assess how the different FA affected the oxidative status of
muscle, we measured lipid hydroperoxides and TBARS as markers of lipid peroxidation,
protein carbonylation as a marker of oxidative damage to proteins and the antioxidant
enzymes GPx (activity) and SOD2 (protein content). Consistent with previous studies (48,
49), these oxidative markers were increased in muscle of mice fed the LCFA-rich diet (with
the exception of SOD2), as well as in C2C12 myotubes after overnight treatment with various
LCFA. However, MCFA-treated mice and cells displayed no evidence of oxidative stress,
with oxidative damage markers and antioxidant protection remaining similar to controls
(GPx, LOOH, protein carbonyls) or being even decreased (TBARS, SOD2). These results
highlight that MCFA do not promote oxidative stress in muscle and this may be an additional
mechanism explaining why high-fat diets containing MCFA do not cause the same
deterioration in glucose homeostasis and insulin action as LCFA (5). Furthermore, as
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antioxidant systems are expected to respond to the need of tissues for protection (24), the
decrease in SOD2 protein content (and similar GPx activity) further supports the low
oxidative stress levels observed with the MCFA diet.
Changes of UCP3 expression are not only used as a marker of mitochondrial oxidative
metabolism (50), but also as an oxidative stress marker (51). Negre-Salvayre and colleagues
were first to suggest a role for UCPs in regulating mitochondrial ROS production (52).
Nowadays, several transgenic model systems suggest that UCP3 is able to curtail superoxide
production by acting as a mild mitochondrial uncoupler (53, 54). MCFA-mice displayed an
88% increase in UCP3 content in skeletal muscle, whereas UCP3 only showed a tendency
towards an increase with the LCFA-diet (+40%). The elevated UCP3 content in MCFA-fed
mice might also partly explain their decreased H2O2 generation and electron leakage, as well
as their increased oxygen consumption.
MCFA have been reported to improve insulin action and glucose homeostasis in various
experimental models. Type 2 diabetic subjects treated acutely with MCFA for 5 days showed
an improvement in insulin-stimulated glucose disposal (55). Similarly, Han and colleagues
showed a decrease in body weight, HOMA-IR and fasting insulin in type 2 diabetic subjects
that consumed diets supplemented with MCFA for 3 months when compared to subjects
consuming LCFA-rich diets (56). Comparable beneficial effects have also been reported in
various rodent models (4, 5, 8, 57) and in muscle cells (58). To test if some of the beneficial
effects of MCFA on insulin action might be related to changes in insulin signalling, we
determined the phosphorylation status of the key insulin signalling intermediates IRS1, Akt
and GSK3β in muscle cells. Compared to control cells, insulin-induced Akt phosphorylation
was significantly increased after MCFA treatment, but was unchanged or even decreased (in
the case of palmitic acid) after LCFA treatment. Similarly, phosphorylation of GSK3β was
unchanged in MCFA-treated cells but decreased after LCFA-treatment. Changes in GSK3β
phosphorylation were accompanied by a similar pattern in the rate of insulin-stimulated
glycogen synthesis, which was significantly reduced in the LCFA-treated cells. Thus,
although there is still controversy regarding the exact relationship between alterations in the
activation state of insulin signalling intermediates and endpoint measures of insulin action
(e.g. glucose uptake) (59, 60), our results indicate that MCFA display enhancing effects on
both the insulin signalling intermediates, as well as on glycogen synthesis, which is
commonly used as an endpoint measure of insulin action in cell culture systems (61, 62).
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In conclusion, our study has revealed that MCFA increase oxidative metabolism at the level
of the mitochondrion in muscle. Furthermore, in contrast to LCFA, MCFA prevent the
induction of oxidative stress that normally arises due to excess lipid intake. Our results in
myotubes indicate that capric and lauric acid (C10:0 and C12:0) are most likely responsible
for the observed effects, with these two FA comprising more than 40% of the total FA
content in our MCFA-diet (8). Overall these findings provide new insight into the
mechanisms that contribute to the favourable effects of MCFA on energy homeostasis and
insulin action.
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Figure Legends
Figure 1. Metabolic activity of C2C12 myotubes. Oxygen consumption (A), succinate
dehydrogenase activity (B), immunoblotting for oxidative proteins (C), triacylglycerol levels
(D) and fatty acid uptake (E) were measured in muscle cells treated with various MCFA or
LCFA (18 hour incubations with 200µM FA). Fatty acid uptake was measured after 18hrtreatment with the respective fatty acids, followed by a 1 hour-incubation with either
lauric acid (for C and MCFA treated cells) or

14

14

C-

C-palmitic acid (for C and LCFA treated

cells), and was calculated as the sum of FA that were funnelled into oxidative and storage
pathways (see methods for details). Shown are means ± SEM, n=3 with 3 replicates each (or
2 replicates in the case of panel A); * p<0.05, ** p<0.001 vs. C; # p<0.01 vs. CA, ^ p<0.01
vs. LA. C = control, CA = capric acid, LA = lauric acid, PA = palmitic acid, OA = oleic acid,
LinA = linoleic acid
Figure 2. Oxidative stress markers in C2C12 myotubes. Mitochondrial (A) and cytosolic (B)
superoxide generation, lipid hydroperoxide (B) and TBARS (C) levels in muscle cells treated
with various MCFA and LCFA (18 hour incubations with 200µM FA). Shown are means ±
SEM, n=3 with 3 replicates each (or n=4 with 2 replicates each in the case of panel B); *
p<0.05, ** p<0.01 and *** p<0.001 vs. C; # p<0.01 vs. CA, ^ p<0.01 vs. LA, ɛ p<0.05 vs.
PA, ϕ p<0.01 vs. OA. C = control, CA = capric acid, LA = lauric acid, PA = palmitic acid,
OA = oleic acid, LinA = linoleic acid
Figure 3. Insulin signalling and glycogen synthesis in C2C12 myotubes. (A) Immunoblotting
results in basal and insulin-stimulated muscle cells after 18 hours incubation with various
MCFA and LCFA, and 30min stimulation with 10nM insulin. Representative blots show n=2
per group, but graphed changes represent n=4-6 (2-3 independent experiments). (B)
Glycogen synthesis rate of FA-treated cells in the absence or presence of 100nM Insulin,
measured using 14C-labelled glucose. Bar graphs show means ± SEM. Statistical analysis was
measured by 1-way ANOVA using the ratios between basal and insulin-stimulated protein
levels in each treatment group with * p<0.05, * p<0.01 and *** p<0.001 vs. C cells. C =
control, CA = capric acid, LA = lauric acid, PA = palmitic acid, OA = oleic acid, LinA =
linoleic acid, p = phospho, t = total
Figure 4. Metabolic markers in mice fed CHOW-, MCFA- and LCFA-rich diets. Body
weight (A), fat pad weight (B), oxygen consumption (C), respiratory exchange ratio (D),
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blood glucose levels during a glucose tolerance test (GTT) (E) and fasting plasma insulin
levels (F). For the GTT, glucose (2 g/kg) was injected at the 0 time point, and blood glucose
levels were monitored for 90 after injection. Shown are means ± SEM, n=6-8 per diet group;
* p<0.05, ** p<0.01 and *** p<0.001. Significance values in panel E represent differences in
the area-under-the-curve during the GTT.
Figure 5. Muscle lipid accumulation in mice fed CHOW-, MCFA- and LCFA-rich diets.
Total triacylglyceride (A), ceramide and diacylglyceride levels (B) and ceramide species (C)
in quadriceps muscle. Shown are means ± SEM, n=6-8 per diet group; * p<0.05, ** p<0.01
and *** p<0.001. C = Chow, M = MCFA and L = LCFA
Figure 6. Mitochondrial respiration and hydrogen peroxide production in muscle from
CHOW-, MCFA- and LCFA-fed mice. Mitochondrial oxygen consumption was measured in
state 2, state 3 and state 4 using succinate (A) or palmitoyl carnitine (B) as a substrate.
Hydrogen peroxide production was measured in the presence of succinate, succinate plus
rotenone and palmitoyl carnitine (C). H2O2 production and state 2 oxygen consumption were
used to calculate the percentage of electrons which leak out of sequence producing
superoxide and subsequently hydrogen peroxide, the free radical leak (D). Shown are means
± SEM; n=6-8 for diet group; * p<0.05, ** p<0.01 and *** p<0.001.
Figure 7. Markers of mitochondrial metabolism in skeletal muscle mitochondria.
Representative immunoblotting results of oxidative markers in mice fed CHOW-, MCFA- or
LCFA-rich diets. Shown are n=4 for each group, but percentage changes represent n=6-8; *
p<0.05, ** p<0.01 and *** p<0.001. Complex I–V represent subunits of the complexes of the
ETC. Porin was used as mitochondrial loading control and shows similar distribution in all
diet groups.
Figure 8. Oxidative stress markers in muscle from CHOW-, MCFA- and LCFA-fed mice.
Glutathione peroxidase activity (A), protein carbonylation (B), lipid hydroperoxide (C) and
TBARS levels (D). Shown are means ± SEM; n=6-8 for diet group; * p<0.05, ** p<0.01 and
*** p<0.001
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